Literature DB >> 31145973

IRF2BP2 modulates the crosstalk between glucocorticoid and TNF signaling.

A B M Kaiser Manjur1, Joanna K Lempiäinen1, Marjo Malinen2, Jorma J Palvimo3, Einari A Niskanen4.   

Abstract

IRF2BP2 (interferon regulatory factor-2 binding protein-2) is an uncharacterized interaction partner of glucocorticoid (GC) receptor (GR), an anti-inflammatory and metabolic transcription factor. Here, we show that GC changes the chromatin binding of IRF2BP2 in natural chromatin milieu. The GC-induced IRF2BP2-binding sites co-occur with GR binding sites and are associated with GC-induced genes. Moreover, the depletion of IRF2BP2 modulates transcription of GC-regulated genes, represses cell proliferation and increases cell movement in HEK293 cells. In A549 cells, the depletion extensively alters the responses to GC and tumor necrosis factor α (TNF), including metabolic and inflammatory pathways. Taken together, our data support the role of IRF2BP2 as a coregulator of both GR and NF-κB, potentially modulating the crosstalk between GC and TNF signaling.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Dexamethasone; Glucocorticoid receptor (GR); Interferon regulatory factor-2 binding protein-2 (IRF2BP2); Nuclear factor-κB (NF-κB); Tumor necrosis factor α (TNF)

Year:  2019        PMID: 31145973     DOI: 10.1016/j.jsbmb.2019.105382

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  7 in total

1.  BCOR-coupled H2A monoubiquitination represses a subset of androgen receptor target genes regulating prostate cancer proliferation.

Authors:  Joanna K Lempiäinen; A B M Kaiser Manjur; Marjo Malinen; Kirsi Ketola; Einari A Niskanen; Jorma J Palvimo
Journal:  Oncogene       Date:  2020-01-10       Impact factor: 9.867

2.  Chemical systems biology reveals mechanisms of glucocorticoid receptor signaling.

Authors:  Nelson E Bruno; Jerome C Nwachukwu; Sathish Srinivasan; Charles C Nettles; Tina Izard; Zhuang Jin; Jason Nowak; Michael D Cameron; Siddaraju V Boregowda; Donald G Phinney; Olivier Elemento; Xu Liu; Eric A Ortlund; René Houtman; Diana A Stavreva; Gordon L Hager; Theodore M Kamenecka; Douglas J Kojetin; Kendall W Nettles
Journal:  Nat Chem Biol       Date:  2021-01-28       Impact factor: 15.040

3.  Transient deSUMOylation of IRF2BP proteins controls early transcription in EGFR signaling.

Authors:  Sina V Barysch; Nicolas Stankovic-Valentin; Tim Miedema; Samir Karaca; Judith Doppel; Thiziri Nait Achour; Aarushi Vasudeva; Lucie Wolf; Carsten Sticht; Henning Urlaub; Frauke Melchior
Journal:  EMBO Rep       Date:  2021-01-22       Impact factor: 8.807

4.  Whole-exome sequencing in a subject with fluctuating neuropsychiatric symptoms, immunoglobulin G1 deficiency, and subsequent development of Crohn's disease: a case report.

Authors:  Harumi Jyonouchi; Lee Geng
Journal:  J Med Case Rep       Date:  2022-05-11

5.  SUMOylation regulates the protein network and chromatin accessibility at glucocorticoid receptor-binding sites.

Authors:  Ville Paakinaho; Joanna K Lempiäinen; Gianluca Sigismondo; Einari A Niskanen; Marjo Malinen; Tiina Jääskeläinen; Markku Varjosalo; Jeroen Krijgsveld; Jorma J Palvimo
Journal:  Nucleic Acids Res       Date:  2021-02-26       Impact factor: 16.971

6.  Inflammatory Environment Promotes the Adhesion of Tumor Cells to Brain Microvascular Endothelial Cells.

Authors:  Ke Wang; Shuang Dong; Doaa Higazy; Lijing Jin; Qingcui Zou; Haowei Chen; Aakif Inayat; Sheng Hu; Min Cui
Journal:  Front Oncol       Date:  2021-06-16       Impact factor: 6.244

7.  Construction of a MicroRNA-mRNA Network Underlying Decidualized Endometriotic Cyst Stromal Cells Using Bioinformatics Analysis.

Authors:  Junzui Li; Bin Zhao; Cui Yang; Qionghua Chen
Journal:  Biomed Res Int       Date:  2020-08-19       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.